CK2/PIM1-IN-1
CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 292640-28-9
- Formule: C15H9NO4S2
- Masse moléculaire:331.37
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
|
CK2 3.787 μM (IC50) |
PIM1 4.327 μM (IC50) |
In Vitro
CK2/PIM1-IN-1 a PIM kinases and CK2 inhibitor extracted from patent WO2010148351A1, Compound Example 64[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 292640-28-9
-
Masse moléculaire 331.37
-
Formule C15H9NO4S2
-
SMILES
O=C(O)C1=CC=CC=C1C2=CC=C(/C=C(SC(N3)=S)\C3=O)O2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)